QR-koodi

Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?

Despite significant progress in cancer prevention, screening, and treatment, the still limited number of therapeutic options is an obstacle towards increasing the cancer cure rate. In recent years, many efforts were put forth to develop therapeutics that selectively target different components of th...

Täydet tiedot

Tallennettuna:
Päätekijät: Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, Fabien Granier, Corinne Prévostel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2024-07-01
Sarja:Pharmaceuticals
Aiheet:
Wnt/β-catenin
cancer therapy
small molecule inhibitors
drug design
drug profiling
drug combination
Linkit:https://www.mdpi.com/1424-8247/17/7/949
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia